trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Many Americans will be diagnosed with cancer during their lifetimes.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that many Americans will be diagnosed with cancer during their lifetimes?

Yes. Epidemiological data and large-scale population studies in the United States consistently demonstrate that a significant proportion of Americans receive a cancer diagnosis during their lifetimes.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The claim is specific and empirical, addressing lifetime cancer diagnosis rates in the United States. Multiple retrieved papers analyze US cancer epidemiology, incidence, and large patient cohorts (e.g., SEER data and Medicare data), supporting the proposition that many individuals are diagnosed with cancer over their lifetimes.

Evidence for · 3
Causes of death after breast cancer diagnosis: A US population‐based analysis
2019
This study evaluates large US population-based cohorts involving hundreds of thousands of cancer diagnoses.
Get citation
Afifi, A. M., Saad, A. M., Al‐Husseini, M. J., Elmehrath, A. O., Northfelt, D. W., & Sonbol, M. B. (2019). Causes of death after breast cancer diagnosis: A US population‐based analysis. doi.org. https://doi.org/10.1002/cncr.32648

See more details
More for · 2
Global landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries: a population-based study.
2026
This study analyzes global lifetime risks of cancer incidence across 185 countries, including the United States.
Get citation
L, L., K, S., X, L., Y, Y., H, L., S, W., W, C., & R, Z. (2026). Global landscape and temporal trends in lifetime risk of colorectal cancer in 185 countries: a population-based study.. doi.org. https://doi.org/10.20892/j.issn.2095-3941.2025.0851

Targeted Therapy, Immunotherapy, and Molecular Testing in Advanced Solid Tumors: A Medicare Analysis.
2026
This study analyzes tens of thousands of Medicare beneficiaries with incident solid tumor diagnoses in the United States.
Get citation
O, B. & Y, S. (2026). Targeted Therapy, Immunotherapy, and Molecular Testing in Advanced Solid Tumors: A Medicare Analysis.. doi.org. https://doi.org/10.1002/cam4.72279

What does the evidence say?

The claim is specific and empirical, addressing lifetime cancer diagnosis rates in the United States. Multiple retrieved papers analyze US cancer epidemiology, incidence, and large patient cohorts (e.g., SEER data and Medicare data), supporting the proposition that many individuals are diagnosed with cancer over their lifetimes.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work